Catalyst Wire Dossier Catalyst Wire Dossier

SAXAGLIPTIN AND METFORMIN

saxagliptin and metformin · Mylan Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SAXAGLIPTIN AND METFORMIN, covering 2023-07-31 to 2026-08-11. Get the full timeline:

Most recent: FDA Approved: SAXAGLIPTIN AND METFORMIN — Supplemental Application (Mylan Pharmaceuticals Inc.)

See pricing